Literature DB >> 8442258

Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation.

R Mañez1, M Kobayashi, S Takaya, O Bronsther, D Kramer, H Bonet, Y Iwaki, J J Fung, A J Demetris, T E Starzl.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8442258      PMCID： PMC2967757     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

Review 1.  Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction.

Authors:  T E Starzl; M Ishikawa; C W Putnam; K A Porter; R Picache; B S Husberg; C G Halgrimson; G Schroter
Journal:  Transplant Proc       Date:  1974-12       Impact factor: 1.066

2.  Qualitative testing for circulating immune complexes by use of zone electrophoresis on agarose.

Authors:  R H Kelly; M A Scholl; V S Harvey; A G Devenyi
Journal:  Clin Chem       Date:  1980-03       Impact factor: 8.327

3.  Successful liver transplantation from crossmatch-positive donors.

Authors:  S Iwatsuki; Y Iwaki; T Kano; G Klintmalm; L J Koep; R Weil; T E Starzl
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

4.  The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors.

Authors:  S Takaya; O Bronsther; Y Iwaki; K Nakamura; K Abu-Elmagd; A Yagihashi; A J Demetris; M Kobayashi; S Todo; A G Tzakis
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

5.  The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors.

Authors:  E Mor; G B Klintmalm; T A Gonwa; H Solomon; M J Holman; J F Gibbs; I Watemberg; R M Goldstein; B S Husberg
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939
  5 in total
  7 in total

1.  Clinical xenotransplantation.

Authors:  Thomas E Starzl; Noriko Murase; Andreas Tzakis; John J Fung; Satoru Todo; Anthony J Demetris; Rafael Manez; Ignazio R Marino; Luis Valdivia
Journal:  Xenotransplantation       Date:  1994-08       Impact factor: 3.907

2.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

Review 3.  The biological basis of and strategies for clinical xenotransplantation.

Authors:  T E Starzl; L A Valdivia; N Murase; A J Demetris; P Fontes; A S Rao; R Manez; I R Marino; S Todo; A W Thomson
Journal:  Immunol Rev       Date:  1994-10       Impact factor: 12.988

Review 4.  Prospects of clinical xenotransplantation.

Authors:  T E Starzl; A Tzakis; J J Fung; S Todo; A J Demetris; R Manez; I R Marino; L Valdivia; N Murase
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

5.  Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.

Authors:  Jacqueline G O'Leary; Hugo Kaneku; Anthony J Demetris; John D Marr; S Michelle Shiller; Brian M Susskind; Glenn W Tillery; Paul I Terasaki; Göran B Klintmalm
Journal:  Liver Transpl       Date:  2014-01-02       Impact factor: 5.799

Review 6.  Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.

Authors:  Antonio Cuadrado; David San Segundo; Marcos López-Hoyos; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

7.  Baboon-to-human liver transplantation.

Authors:  T E Starzl; J Fung; A Tzakis; S Todo; A J Demetris; I R Marino; H Doyle; A Zeevi; V Warty; M Michaels
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.